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Recent advances in angiographic technique have raised our awareness of the presence of unruptured intracranial aneurysms
(UIAs).However,theappropriatemanagementfortheselesionsremainscontroversial.Tooptimizepatientoutcomes,thephysician
must weigh aneurysmal rupture risk associated with observation against the complication risks associated with intervention. In
the case that treatment is chosen, the two available options are surgical clipping and endovascular coiling. Our paper summarizes
the current body of literature in regards to the natural history of UIAs, the evolution of the lesion if it progresses uninterrupted, as
well as the safety and eﬃcacy of both treatment options. The risks and beneﬁts of treatment and conservative management need
to be evaluated on an individual basis and are greatly eﬀected by both patient-speciﬁc and aneurysm-speciﬁc factors, which are
presented in this paper. Ultimately, this body of data has led to multiple sets of treatment guidelines, which we have summated
and presented in this paper.
1.Introduction
Despite an abundance of published data, management of
patients with unruptured intracranial aneurysms (UIAs)
remains controversial. Advances in imaging and more fre-
quent use of CTA and MRA over the last two decades
have elucidated the pervasiveness of intracranial aneurysms.
Furthermore, these imaging techniques have been reﬁned
over the years giving them greater sensitivity and speciﬁcity
and increasing the number of cerebral aneurysms found
incidentally. Ultimately, physicians have realized that UIAs
are rather common. Imaging studies have reported frequen-
cies of 0.5% to 2%, while autopsy studies have reported
f r e q u e n c i e so f1 %t o9 %[ 1].
The inherent threat of UIAs is rupture and subsequent
subarachnoidhemorrhage(SAH).Recentstudiesofaneurys-
mal SAH, which accounts for around 80% of nontraumatic
SAH, have reported 1-month case mortality rates as high
as 30% to 50% [2–4]; these devastating outcomes are still
extraordinary. Poor neurologic and functional outcomes
among patients whom have suﬀered SAH are due to initial
hemorrhage, early rebleeding, and delayed cerebral ischemia
resulting from cerebral vasospasm, microvascular dysfunc-
tion, and complex neuronal-glial interactions [5]. Therefore,
preventive measures must be taken to better predict rupture
risk of UIAs.
Universal treatment protocols for patients with UIAs
have yet to be established. Intervention by surgical clipping
or endovascular coiling constitutes one strategy, while others
have opted for conservative management and observation.
Chief in this clinical evaluation is balancing the risk of
treatment with that of observation. A variety of largely
nonrandomized studies have implicated diﬀerent patient
characteristics (age, medical condition, history of SAH, etc.),2 International Journal of Vascular Medicine
Table 1: Key ﬁndings related to the natural history data.
Risk factor Key ﬁndings References
Size
(i) Larger UIAs have greater RR
(ii) Aneurysm size is a signiﬁcant independent predictor of RR
(iii) Deﬁning a critical size threshold for aneurysm rupture
remains diﬃcult
ISUIA investigators 1998 [7]
Wiebers et al. 2003 [8]
Ishibashi et al. 2009 [9]
Enlargement
(i) In most cases, IAs are larger at time of rupture than at initial
diagnosis
(ii) Larger UIAs are more likely to grow
(iii) Larger UIAs → greater growth risk → increased RR
Yasui et al. 1996 [10]
Burns et al. 2009 [1]
Matsubara et al. 2004 [11]
Previous SAH
(i) Prior history of aneurysmal SAH increases future RR
(ii) Aneurysms <7mm have an increased RR with prior history
of SAH
ISUIA investigators 1998 [7]
Wiebers et al. 2003 [8]
Location
(i) Posterior circulation aneurysms are widely considered to be
more hazardous
(ii) Include basilar artery, posterior cerebral artery, and
vertebrobasilar distribution
(iii) Intracavernous IAs are more benign
Weir et al. 2002 [12]
Wermer et al. 2007 [13]
Kupersmith et al. 1992 [14]
Morphology
(i) Multiple lobulations or loculations increases RR
(ii) High dome:neck ratio increases RR
(iii) Aneurysm angle, undulation index, and nonsphericity
index are all predictors of aneurysm rupture
Hademenos et al. 1998 [15]
Beck et al. 2003 [16]
Dhar et al. 2008 [17]
Raghavan et al. 2005 [18]
Patient
characteristics
(i) Age, sex and comorbidities will inﬂuence aneurysmal RR
(ii) Female sex and cigarette smoking are independent
predictors of both UIA formation and growth
(iii) These factors are especially important when making
decision on whether to treat
Nahed et al. 2005 [19]
Juvela et al. 2001 [20]
aneurysm characteristics (size, location, morphology, neck
size, etc.) and management factors (surgical team, treating
hospital), as being inﬂuential in the natural history and
outcomes following treatment [6]. This paper will thor-
oughly review the current literature regarding the natural
history and treatment options for UIAs and present current
guidelines for treatment.
2. NaturalHistory of UIAs
Characterizing the aneurysmal rupture risk of UIAs, known
as their natural history, is a task that has proven very
diﬃcult over the years. While much has been revealed
about UIAs from retrospective review, inconsistencies and
methodological ﬂawsin studies regarding UIAs have resulted
in a poorly deﬁned natural history. Several reasons explain
why this uncertainty exists. Paramount among them is the
fact that natural history studies of UIAs only evaluate those
patients for whom conservative management was decided. It
has therefore been argued that data from these studies do
not represent the behavior of all UIAs, only certain types.
The current body of published literature has thoroughly
evaluated aneurysms on the basis of many diﬀerent risk
factors, which can be roughly divided into patient-speciﬁc
and aneurysm-speciﬁc factors. Table 1 lists the important
factors aﬀecting the natural history of UIAs and provides key
ﬁndings related to each.
2.1. Size as a Risk Factor for Rupture. In almost all natural
history studies to date, size has been found to be a signiﬁcant
predictor of aneurysm rupture. In general, the notion that
large UIAs have a greater rupture risk than small UIAs is
widely accepted. However, an exact size threshold above
which UIAs impart signiﬁcantly greater rupture risk has yet
to established [21].
The largest multicenter study of UIAs at the time,
the ISUIA (International Study of Unruptured Intracranial
Aneurysms), aimed to characterize the natural history of
unruptured aneurysms. The retrospective cohort of the
ISUIA study found that, in patients without previous history
of SAH, UIAs of less than 10mm in diameter had a rupture
rate (RR) of 0.05% per year. It also found that UIAs more
than 10mm in diameter had an RR of less than 1% per year.
The authors initially concluded that UIAs were more benign
than previously reported [7]. The follow-up, prospective
arm of the ISUIA performed a similar analysis on those
patients who were chosen for conservative management but
employed diﬀerent size thresholds of 7mm, 12mm, and
25mm. Of the 1077 conservatively managed patients who
displayed no prior history of SAH, 41 suﬀered aneurysm
rupture of which only 2 were from aneurysms less than
7mm[8]. After analyzing both branches of their study, the
investigators of the ISUIA concluded that size certainly plays
an essential role in the assessment of rupture risk, but cannot
be evaluated independent of all other factors.
More recent natural history studies continue to reinforce
the importance of size in evaluating rupture risk. A study by
Ishibashi et al. classiﬁed aneurysms by size, small (<5mm),
medium (5–9.9mm), large (>10mm), and giant (>25mm),
and found annual RRs of 0.8%, 1.2%, 7.1%, and 43.1%,International Journal of Vascular Medicine 3
respectively [9]. Additionally, a meta-analysis performed by
Wermer et al. of more than 4700 patients and 6500 UIAs
taken from 19 studies worldwide revealed that UIAs from
5mm–10mm and >10mm had rupture risks 2.8 times
and 5.2 times greater than aneurysms <5mm. While it is
apparent that aneurysmal size is signiﬁcant, the inconsistent
statistical analyses among these studies make deﬁning a
critical size threshold for UIAs diﬃcult.
2.2. Enlargement as a Risk Factor for Rupture. The growth
of UIAs over time is important to the clinician for multiple
reasons. For one, it has been hypothesized that an increase
in UIA size might be indicative of forthcoming rupture,
even in smaller aneurysms. One study by Yasui et al.
speciﬁcally analyzed 25 cases of SAH caused by rupture of
a conservatively managed intracranial aneurysm. The results
of this study found that in most cases the diameter at time
of rupture was greater than the diameter at initial diagnosis.
Furthermore, of these 25 cases, 16 dealt with aneurysms
that were <5mm at initial diagnosis [10]. Therefore, despite
initial size, it is important to understand aneurysmal growth
patterns to guide maintenance and followup.
Another study, completed in 2008 by Burns et al.,
evaluated enlargement as a risk factor for aneurysm rupture.
The study retrospectively identiﬁed 165 patients with 191
UIAs followed with serial MR angiography and discovered
that, after a median follow-up period of 47 months, 20
aneurysms (∼10%) grew. Frequency of enlargement was
6.9%, 25%, and 83% for aneurysms <8mm, 8 to 12mm,
and ≥13mm, respectively [1]. Of the variables evaluated,
which included patient age and aneurysm location, original
aneurysm diameter was the only independent predictor of
enlargement. Similarly, a study by Matsubara et al. focused
on the risk factors for UIA growth when the chosen angio-
graphic technique was CTA. Growth was identiﬁed in 6.4%
of all aneurysms, with aneurysms of 2–4mm, 5–9mm, and
10–20mm, producing growth frequencies of 2.4%, 9.1%,
and 50%, respectively [11]. It can thus be concluded that
havinglargeraneurysmswillincreasetheriskofenlargement
and consequently might accelerate aneurysmal rupture.
2.3. Previous Subarachnoid Hemorrhage as a Risk Factor
for Rupture. Among the chief goals of the ISUIA was
better understanding the role that previous medical history,
particular one with aneurysmal SAH, had on future rupture
risk. Consequently, the retrospective component of the
ISUIA, stratiﬁed its patients into two groups, with group 1
consisting of patients who had no history of SAH and group
2 consisting of patients who had a history of SAH from
ad i ﬀerent aneurysm. The patients in group 2 with UIAs
<10mm possessed an RR of 0.5% per year, a ﬁgure which
is ∼11 times higher than that for patients in group 1 with
aneurysms of the same size [7]. The same groupings were
made in the prospective branch of the ISUIA to allow for
similar analysis, but diﬀerent size thresholds were employed.
This branch of the study reported that patients in group 2
with aneurysms <7mm had similar RR as patients in group
1 with aneurysms >7mm, both of which were signiﬁcantly
higher RRs than patients in group 1 with aneurysms <7mm
[8]. Overall, the natural history data from both branches of
the ISUIA conﬁrmed hypotheses, which asserted that a prior
history of SAH increases aneurysmal rupture risk.
2.4. Location as a Risk Factor for Rupture. As the various
cerebral blood vessels have diﬀerent characteristics and
experience diﬀerent hemodynamic conditions, one would
expect location of the aneurysm to inﬂuence its natural
history. Some studies had originally identiﬁed aneurysms
at the anterior communicating and pericallosal arteries as
being at high risk of rupture [12, 22]. However, the cerebral
arteries that are now considered most hazardous are located
in the posterior circulation and include the tip of the basilar
artery, posterior cerebral artery, vertebrobasilar distribution,
andtheoriginoftheposteriorcommunicatingartery[23].In
fact, the only clear, independent predictor of future rupture
among patients with a history of SAH in the ISUIA was
basilar tip location. A study performed by Ishibashi et al.
foundthatposteriorcirculationlocationwasanindependent
predictor of aneurysm rupture and that aneurysms in these
locations had a hazard ratio of 2.9 [9]. Likewise, the meta-
analysis performed by Wermer et al. in 2007 found posterior
circulation location to be a statistically signiﬁcant risk factor
for aneurysmal rupture [13].
On the other hand, UIAs in the intracavernous ICA
have been found to be more benign. This portion of the
ICA is seldom located in the subarachnoid space, and
thus rupture of these aneurysms rarely causes SAH [14].
Further, their natural history suggests that a large number
of such aneurysms will remain clinically asymptomatic [24]
and carry signiﬁcantly lower rates of rupture and mortal-
ity compared to aneurysms situated in the subarachnoid
compartment [25]. The prospective branch of the ISUIA
found that intracavernous aneurysms had a 0.15 relative risk
compared to aneurysms in other portions of the ICA [8].
2.5. Morphological Characteristics as Risk Factors for Rupture.
Atypical aneurysm morphology, such as multilobulation
and loculations, daughter sac formation, and other unique
hemodynamic factors play roles in raising the risk of rupture
[26]. Hademenos et al. completed a study involving 74
patients, with 40 ruptured and 34 unruptured aneurysms
evaluating location and lobulations [15]. They reported
that 16 (84%) of 19 multilobulated aneurysms had rup-
tured, compared with only 24 (44%) of 55 unilobular
aneurysms. Posterior circulation aneurysms were also noted
to be of higher risk with multilobular posterior circulation
aneurysms at the highest risk of all [27]. Similarly, Beck et
al. explored the diﬀerence between ruptured and unruptured
aneurysms in regards to lobulation, the presence of a
daughter sac, or the shape as measured by the height/neck
ratio[16].Theyusedbiplanedigitalsubtractionangiography
(DSA) to analyze the aneurysms in their retrospectively
analysis of 124 patients including 53 unruptured and 94
ruptured aneurysms. 10% of unruptured aneurysms showed
a multilobular appearance on DSA compared with 20%
of ruptured aneurysms. In the 5–9mm aneurysm group,4 International Journal of Vascular Medicine
multiple lobes were found in 26% of ruptured aneurysms.
A height/neck ratio of less than 1.5 was not found in any of
the unruptured aneurysms but was found in 21% (12/57)
of the ruptured aneurysms. The data supported the theory
that aneurysms with multilobular appearance have greater
frequency of rupture.
Given that intracranial aneurysms are more commonly
found at either bi- or trifurcations or at regions of high
impact from ﬂowing blood, the relationship of aneurysm
to the surrounding vasculature has been examined [27].
With respect to the surrounding vasculature, Sadatomo et al.
reported on the relationship among aneurysm neck, parent
artery, and daughter branches in 44 cases (20 unruptured,
24 ruptured) of middle cerebral artery aneurysm [28]. When
the neck was located on the extension of the midline of the
parentartery,itwasdeﬁnedasTypeC(19cases);whenitwas
not, it was deﬁned as Type D (25 cases). They found that in
all cases, Type D aneurysms were located on the side of the
daughter artery with a narrower angle to the parent artery.
In >90% of the cases, the aneurysm was located on the side
of the smaller artery, suggesting that the dominant artery
provided the hemodynamic force for aneurysm formation
and likely increased rupture risk. Furthermore, Type C as
well as a high dome/neck ratio is associated with increased
aneurysmal rupture risk [28].
Novel technology providing three-dimensional angio-
graphic images has facilitated visualization of cerebral vas-
culature and helped investigators analyze aneurysm mor-
phology. Dhar et al. utilized this technology to evaluate
UIAs based on eight parameters, three of which incorporate
parentvesselgeometryandhadnotbeenpreviouslyexplored
(vessel angle, aneurysm (inclination) angle, and (aneurysm-
to-vessel) size ratio) [17]. Of the parameters examined, size
ratio and aneurysm angle (with respect to the parent artery)
had the strongest correlation to rupture risk. Still, another
group of investigators found that the undulation index
and Nonsphericity index, diﬀerent metrics of aneurysm
morphology, have strong correlations to UIA rupture risk
[18]. Nonsphericity index characterizes the deviation of UIA
from that of a perfect sphere by using aneurysm volume and
surface area, and undulation index characterizes the number
and size of concave regions on the surface of the aneurysm.
2.6.Patient-SpeciﬁcCharacteristicsasRiskFactorsforRupture.
Patient factors such as age, sex (females are 1.5–3 times more
likely to have a ruptured aneurysm), and comorbidities, such
as hypertension and cigarette smoking, inﬂuence whether
an aneurysm will rupture [19]. 87 patients were involved
in a long-term study conducted by Juvela et al.. 79 of the
patients had ruptured aneurysms clipped at the start of
followup. There were 111 unruptured aneurysms as well as
an additional 7 patients (2 with and 5 without unruptured
aneurysms) who developed new aneurysms. The patients
were followed from the 1950s to the 1970s until death,
subarachnoidhemorrhage,oruntilthelastcontact;themean
follow-up period was 18.9 years. Unruptured aneurysms
increased in size ≥1mm in 39 of the 87 patients (45%) and
≥3m mi n3 1( 3 6 % ) .N e wa n e u r y s m sw e r ef o u n di n1 5o f
the 89 patients and in 5 without an unruptured aneurysm
at the beginning of followup. After adjustment of age, the
signiﬁcant risk factors for increased risk of intracranial
aneurysm formation and growth were cigarette smoking
and female sex [20]. Cessation of smoking should therefore
be employed for all patients with unruptured aneurysms
and possibly also for those with a prior subarachnoid
hemorrhage.
3. Treatment Options for UIAs
The most appropriate treatment option for any UIA is that
which provides an optimal balance of procedural safety
and long-term eﬃcacy based on patient and aneurysm
characteristics. Currently, there are two available options
for treating UIAs, microsurgical clipping and endovascular
coiling. For each of these treatment modalities, recurrence,
retreatment, and percent occlusion data have been gathered
to quantify eﬃcacy, while morbidity/mortality and procedu-
ral complication rates have been utilized to quantify safety.
Although the merits of each treatment are well documented,
the superiority of one treatment over the other remains
controversial. This section of the paper presents both the
current data regarding each treatment and the proposed
guidelines set forth to help physicians optimize patient
outcomes.
3.1. Surgical Treatment. Traditionally, surgical clipping has
been viewed as being highly eﬃcacious, but carrying greater
risk due to the neurological complications associated with
open neurosurgery. Eﬃcacy of this treatment is illustrated by
a study performed between 1998 and 2001 that explored the
need for cerebral angiography following surgery for saccular
aneurysms. Of the 315 surgically clipped UIAs in this study,
287 were completely occluded, a 91% complete occlusion
rate [29]. On the other hand, safety concerns associated
with surgical treatment are shown in a report analyzing data
from twenty-one single-center and eight multicenter studies
of surgical clipping from 1991 to 2003 [30]. In this study,
mortality rates ranged from 0% to 6.9%. The same study
found the adverse outcome rate (AOR) to range between
0% and 25.1% with a cumulative AOR of 17.8%. The
inconsistencyinthisanalysismightalsorepresentthevarying
levels of expertise among neurosurgical teams at diﬀerent
institutions.
Another goal of the prospective branch of the ISUIA
was to obtain a more comprehensive assessment of the
surgicalrisksofaneurysmclipping.Amongthe1917patients
who underwent surgical clipping, the study found a 1-year
mortality rate of 2.3% and a 1-year morbidity rate of 12.1%.
The study also found that increasing aneurysmal size and
patient age as well as location in the posterior circulation
(particularlybasilartipandposteriorcommunicationartery)
are indicators of poor outcome following surgical treatment
[8]. Consequently, older patients with large, posterior cir-
culation aneurysms are most likely better candidates for
endovascular treatment.
Based on the natural history data presented in the
ISUIA, Krisht et al. calculated that (according to sizeInternational Journal of Vascular Medicine 5
Figure 1: (a) Preoperative 3D digital subtraction angiogram (DSA) of a left 6.6mm pericallosal UIA. 54-year-old female patient had
prior history of SAH and harbored multiple smaller aneurysms on the right. Endovascular coiling was chosen. (b) Postoperative 3D DSA.
Treatment achieved 99% occlusion.
parameters) patients on their service whom had chosen
surgical treatment would have had a 10-year cumulative
bleeding-related mortality and severe morbidity rate of no
less than 7.5% had they chosen conservative management.
This ﬁgure is signiﬁcantly greater than the 4.2% combined
morbidity and mortality rates that their patient population
actually experienced, suggesting that surgical treatment may
represent a superior approach to conservative management
in patients with life expectancies greater than 10 years [31].
More recent studies are showing that reﬁnement of
microsurgical technique is leading to safer, more eﬃcacious
treatment of UIAs. One study followed a series of 450
aneurysms treated with surgical clipping by one neuro-
surgeon immediately upon completion of neurosurgery
training. With 6-month morbidity and mortality rates of
1.06% and 0.27%, respectively, it is clear that, despite an
increase in endovascular procedures, given proper mentor-
ship and resources prevailing neurosurgeons can achieve
acceptable results when treating UIAs surgically [32]. Even
in populations widely recognized as better candidates for
endovascular treatment, such as those over 65 years old, low
morbidity rates have legitimized surgical clipping as a safe
option [33].
As previously mentioned, the expertise and experience of
the neurosurgical team and treating hospital will also aﬀect
postoperative outcomes. A study at the Cleveland Clinic of
499 aneurysms, treated by 10 neurosurgeons, found that the
number of aneurysms clipped by a speciﬁc neurosurgeon
was a strong predictor of positive outcome, along with
patient age and aneurysm size [34]. In the state of New
York, hospitals that performed greater than 30 craniotomies
per year saw 43% reductions of in-hospital mortality for
the treatment of both ruptured and unruptured aneurysms
[35]. Similarly, a study of the national inpatient sample
(NIS) from 1996 to 2000 showed that patients treated in
high-volume hospitals (treated ≥20 UIAs per year) rather
than low-volume hospitals (treated ≤4U I A sp e ry e a r )h a d
lower adverse outcomes and lower mortality rate (1.6%
versus 2.2%) [36]. Consequently, it is increasingly important
that neurosurgeons understand the limitations of both
their technical capability and their available resources when
making treatment decisions regarding UIAs.
3.2.EndovascularTreatment. Sinceitsconceptionandimple-
mentation about two decades ago [37, 38], endovascular
coil embolization has become a primary treatment in the
management of UIAs. In many institutions worldwide,
endovascular coiling has become the preferred treatment
for UIAs for which intervention is indicated [39]. Figures
1 and 2 provide examples of UIAs successfully treated
with endovascular coil embolization. Whereas physicians
often worry about the safety of open neurosurgery, the
main concern with endovascular techniques is eﬃcacy. Early
eﬃcacy reports perpetuated this viewpoint. A meta-analysis
including 46 studies of patients treated with endovascular
coiling from 1990 to 1997, revealed a rather low complete-
obliteration rate of 54% [40]. Similarly, the prospective arm
of the ISUIA reported a 55% complete obliteration rate, a
24%incompleteobliterationrate,andnoobliterationin18%
of the 451 patients who were treated endovascularly [8].
In addition to degree of occlusion, the eﬃcacy of treat-
ments for UIAs, especially endovascular coiling, has been
measured by recanalization and retreatment rates. These
rates quantify the long-term eﬀectiveness of coiling and help
surgeons and physicians understand how much treatment is
altering the natural history of these lesions. One multicenter
study published by Gallas et al. in 2009 analyzed intracranial
aneurysms treated within ﬁve-year period from 1998 to 2003
and included a mean follow-up time of 55.6 months [41]. Of
232 UIAs treated by endovascular coiling in this study, 172
werecompletelyoccludedand,oftherest,18(7.8%)required
retreatment, most during the ﬁrst postoperative year. These
completeocclusionandretreatmentratesarecertainlyhigher
than those for patients who underwent surgical clipping.
To conﬁrm the notion that endovascular procedures
provide a safe alternative for treating UIAs, many studies
have investigated the morbidity and mortality rates of
patients who underwent endovascular coiling. As part of the
prospective branch of the ISUIA, 451 patients were chosen
to undergo endovascular coiling. Among these patients,
there was a 1-year surgery-related mortality rate of 3.1%
and a 1-year morbidity rate of 9.5% [8]. A year later,
Lanterna et al. analyzed thirty studies of endovascular
coiling, published between 1990 and 2002, and revealed
case-fatality and permanent morbidity rates of 0.6% and6 International Journal of Vascular Medicine
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Figure 2: Preoperative DSA of a 4.1mm × 3.2mm ACOM aneurysm. This speciﬁc UIA was chosen for endovascular treatment due to
enlargement and visual ﬁeld deﬁcits. (b) Postoperative DSA. Endovascular coiling produced near complete occlusion.
7.0%,respectively.Toappreciatetheeﬀectofadvancingtech-
nology and technical reﬁnement, the investigators divided
the publications by midyear of the study and found that
studies before 1995 reported a morbidity rate of 8.6%, while
the morbidity rate of studies after 1995 had dropped to
4.5% [42]. Another more recent meta-analysis performed
by Naggara et al. looked at similar studies performed in 17
diﬀerent countries from 2003 to 2008 and found unfavorable
outcomes occurred at a rate of 4.8% [43]. Ultimately, these
data do seem to indicate that endovascular coiling provides
a safe alternative to coiling by imparting lower complication
rates upon patients.
While endovascular treatment of UIAs is now widely
used, certain aneurysmal morphologies and anatomical
features, particularly a wide neck, render some aneurysms
technically diﬃcult to treat endovascularly. To facilitate
endovascular coiling of aneurysms with broad necks, Moret
et al. extended a previously utilized temporary balloon-
inﬂation technique to the treatment of UIAs and named it
balloon remodeling [44]. One part of the ATENA (Analysis
of Treatment by Endovascular Approach of Nonruptured
Aneurysms) Study explored the safety of the balloon remod-
eling technique. The morbidity and mortality rates of UIAs
treated with balloon remodeling were 2.3% and 1.4%,
respectively, compared to 2.2% and 0.9% for those receiving
standard endovascular coiling, a diﬀerence which was not
statistically signiﬁcant [45]. In terms of eﬃcacy, a review
comparing aneurysms treated with balloon remodeling
versusstandard endovasculartreatment,instudiespublished
from 1997 to 2006, revealed signiﬁcantly higher initial and
follow-up aneurysm occlusion rates for those aneurysms
treated with balloon remodeling [46].
Another adjunctive therapy for wide-neck UIAs is
microcatheter-delivered stenting. The hope among neu-
rosurgeons is that stent-assisted coil embolization (SAC)
may improve long-term durability and eﬀectiveness by
minimizing herniation and increasing packing density [47].
After establishing procedural safety and periprocedural
eﬀectiveness [48], Sedat et al. reported that long-term
complete aneurysmal occlusion occurred in 71% of patients,
with aneurysmal regrowth in 4 out of 38 patients at
ﬁrst angiographic followup and no regrowth in any other
Figure 3: 3D DSA of a giant, left, petrous ICA aneurysm. Stent-
assisted coiling was performed on this patient.
followups [49]. Still, other investigators wanted to fully value
the safety and eﬃcacy of SAC and subsequently created
the Interstate Collaboration of Stent Coiling (ICES). Initial
results of the ICES study concluded that this technique was
helpful for treatment of UIAs but not RIAs and produced
morbidity and mortality rates of 2.8% and 2.0%, respectively
[50]. The midterm report of the ICES study, which then
encompassed216SAC-treatedaneurysms,reportedthat40%
of aneurysms demonstrated complete occlusion and 88%
had≥90%aneurysmocclusion,illustratingthatSACisviable
option for wide-neck aneurysms [51]. Figure 3 presents a
U I Af o rw h i c hS A Cw a st h ec h o s e nt r e a t m e n tm o d a l i t y .
3.3. Comparative Studies of UIA Treatment. For many years,
microsurgical clipping of aneurysms was considered the
“gold standard” of treatment for UIAs. However, emerging
attitudes favoring noninvasive procedures have coincided
with a steep increase in gross number and variety of
aneurysms treated endovascularly [52]. According to NIS
records, the fraction of UIAs treated with endovascular
coiling has risen from 20% in 2001 to 63% in 2008 [53].
As shown above, the amassed literature comparing the two
treatment options, composed primarily of nonrandomized,International Journal of Vascular Medicine 7
retrospective studies, varies considerably in regard to safety
and eﬃcacy data. Consequently, uncertainty over the supe-
riority of one method over another remains, and approaches
totreatmentareoftenbasedlargelyuponopinionorpersonal
experience rather than scientiﬁc evidence.
In order to settle this controversy, many studies have
directly compared endovascular coiling to surgical clipping.
A multicenter retrospective cohort study of over 2500 UIAs
treatedwitheithercoilingorclippingbetween1998and2000
revealed signiﬁcantly lower morbidity (6.6% versus 13.2%)
and mortality (0.9% versus 2.5%) in those patients treated
endovascularly [54]. Furthermore, a recent analysis of the
NIS discovered that the percentage of patients discharged to
long-term care after surgical clipping was 14.0%, compared
to 4.9% for those treated with coiling, and also found an
overall decrease in adverse outcomes in patients treated for
a UIA from 14.8% in 2001 to 7.6% in 2008. They attributed
the increasing safety of these types of procedures to advances
in endovascular technique and expertise [52]. Another
publicationfromthesamestudyoftheNISstratiﬁedpatients
by age and revealed that the higher morbidity and mortality
rates of surgically clipped patients were more pronounced
in the elderly population [55]. This demonstrated safety of
coiling relative to clipping might explain its increased use
over the past decade.
While numerous RCTs have investigated the treatment
safety and eﬃcacy of RIAs [56–58], substantial obstacles
havepreventedcompletionofRCTscomparingthetreatment
options of UIAs. Initiated in 2006, the TEAM trial aimed
to be the ﬁrst true, international RCT comparing endovas-
cular coiling to conservative management [59]. However,
in 2009, the study was terminated due to poor subject
recruitment. Among many other reasons, the authors cite
a pervasive distrust between scientiﬁc research and clinical
care as an explanation for the trials failure [60]. Another,
seemingly more practical, RCT called the CURES (Canadian
Unruptured Endovascular versus Surgery) trial is expected
to evaluate which intervention, coiling or clipping, leads to
better morbidity, mortality, and clinical eﬃcacy in patients
chosen for intervention. Currently the investigators are still
in the pilot phase of the trial in which they will assess the
study’s feasibility and determine the incidence of treatment
failure, deﬁned as incomplete aneurysm obliteration, major
saccular aneurysm remnant, or SAH within a year of
treatment [61].
The clinical evaluation of UIA patients also must con-
sider the economic burdens of each treatment. This reality is
particularly valid when the treatment rationale is unclear, as
is the case in UIA treatment. Investigators in Europe initially
reportedthattherewasnosigniﬁcantdiﬀerencebetweencost
of endovascular coiling and surgical clipping [62]. However,
to explore costs in the United States healthcare system, an
analysisoftheNISpublishedin2011exploredthediﬀerences
in regards to length of hospitalization and hospital charges
between patients who underwent clipping versus coiling. It
found that UIAs patients treated with endovascular coiling
had shorter lengths of stay and, on average, $11,263 less total
hospital charges compared to patients treated with surgical
clipping [63].
3.4. Future Directions of UIA Treatment. The endovascu-
lar approach to UIA treatment, having only been FDA
approved since the early 1990s, remains a relatively new
option. As such, there is still a great deal of research and
innovation occurring in the ﬁeld, which frequently leads
to new technologies. The hope with these advances is
that neurosurgeons will be able to treat a wider spectrum
of intracranial aneurysms with greater safety and eﬃcacy,
loweringincompleteocclusionandrecanalizationrateswhile
maintaining acceptable levels of morbidity and mortality.
While primarily used in the treatment of arteriovenous
malformations (AVMs), liquid embolic systems such as
Onyx HD-500 (EV3, Irvine, CA, USA) are becoming an
increasingly popular option in the treatment of wide-necked
intracranial aneurysms. Compared with standard platinum
coil embolization, liquid embolic systems are posited to
provide greater neck and parent vessel reconstruction while
also inducing greater neoendothelization of the aneurysm
neck. One retrospective study of 84 wide-necked intracranial
aneurysms treated with Onyx HD-500 (74 of which were
unruptured) found there to be an overall complete occlusion
rate of 65.5% immediately following the procedure. Fur-
thermore, 68.2% of the incompletely occluded aneurysms
progressed to complete occlusion by 6 months, and, by
18 months, 90.3% of all aneurysms achieved complete
occlusion. Procedural morbidity and mortality rates in this
study were 7.2% and 2.9%, respectively [64]. A more recent
single-center, prospective study reported that all 13 of their
Onyx HD-500 treated, wide-necked UIAs achieved greater
than 90% occlusion immediately postoperation. This level of
occlusionwasmaintainedinallpatientsat6-monthfollowup
[65].
Another, more recently approved, endovascular ap-
proach is parent vessel reconstruction using a pipeline (EV3,
Irvine, CA, USA) embolization device (PED). Similar to
the microstent, the PED is a self-expanding, microcatheter-
delivered, cylindrical mesh device. However, its 30–35%
metal surface area coverage (compared to the 6–9% coverage
of self-expanding microstents) allows it to function as a
stand-alonereconstructiondevice,divertingbloodﬂowaway
from the aneurysm [66]. In its early stages of development,
the PED has been utilized in cases when standard coil
embolization has been largely ineﬀe c t i v e ,s u c ha sw i d e -
necked, large or giant, and nonsaccular, fusiform aneurysms.
In a recent study of 53 patients harboring 63 aneurysms
approved for compassionate use of PED treatment for large
or giant, wide-necked, nonsaccular aneurysms, no major
complications were noted. Complete occlusion occurred
in 56% of aneurysms at 3-month followup, 93% at 6-
month followup, and 95% at 12-month followup [67]. One
major concern with PED treatment is delayed occlusion,
especially since, at present, it is primarily being utilized to
treat high-rupture-risk aneurysms. Still, the results of this
study indicate that PED could become a safe and eﬀective
treatment of more complex UIAs.
3.5. Treatment Recommendations. In 2000 the American
Heart Association’s Stroke Council published a list of recom-
mendations to provide the physician with a framework8 International Journal of Vascular Medicine
Table 2: Treatment recommendations.
Source Recommendations
American Heart
Association’s Stroke
Council
(1) Treatment of small intracavernous ICAs is not advised. Large intracavernous ICAs should
be considered, taking into account age and symptoms.
(2) Symptomatic intradural ICAs should be considered for treatment. However, large or giant
symptomatic aneurysms require exhaustive consideration of individual patient characteristics
and the expertise of surgeon and facility.
(3) Patient with prior history of aneurysmal SAH should be considered for treatment,
especially for UIAs at the basilar apex
(4) Asymptomatic aneurysms <10mm in patients without prior history of aneurysmal SAH
generally should be observed. Special consideration should be given to patient with family
history or unique hemodynamic factors.
(5) Asymptomatic UIAs ≥10mm warrant strong consideration for treatment.
Mayo Clinic College of
Medicine
(1) With rare exception, all symptomatic UIAs should be treated.
(2) Small incidental aneurysms <5mm should be managed conservatively.
(3) UIAs >5mm in patients younger than 60 years of age should be strongly considered for
treatment.
(4) UIAs >10mm in patients younger than 70 years of age should be strongly considered for
treatment.
(5)Microsurgical clipping rather than endovascular coiling should be the ﬁrst-choice
treatment in low-risk cases.
Columbia University
(1) Patients under the age of 45 should be strongly considered for treatment with exceptions
being small, anterior circulation UIAs.
(2) Aneurysms >12mm should be strongly considered for treatment, except in older patients
and those at high risk of intervention
(3) Conservative management is recommended for patients with UIAs <5mm in anterior
circulation and <3mm in posterior circulation, except if patient is below the age of 45 or has
strong family history
(4) Factors to be considered in all UIA cases include aneurysmal factors such as daughter sac
formation or multiple lobes and patient factors such as family history, age, and comorbidities
(5) Antihypertensive and smoking cessation therapies should be recommended to all patients
with UIAs
(6) Follow-up, noninvasive imaging with MRA or CTA should be done at 6 and 12 months
after diagnosis, followed by yearly imaging for at least 3 years to monitor enlargement.
for making appropriate treatment decisions. In these rec-
ommendations, the council emphasizes patient age in the
clinicalevaluation,notingthatthehighertreatmentrisksand
shorter life expectancies of older people favor observation,
especially in the case of small, asymptomatic UIAs. For
example, conservative management might be suggested for
an older patient with a UIA ≥10mm, while treatment might
be recommended for young patients with UIAs between
5mm and 9mm. Furthermore, the council recommends
treatment for all patients with prior history of aneurysmal
S A Ha sw e l la sa l ls y m p t o m a t i c ,i n t r a d u r a lU I A sa n dU I A s
≥10mm, unless age or medical condition limit treatment
beneﬁts. Additionally, special consideration should be given
to aneurysms with unusual morphology such as multilobu-
lations as well patients with a family history of aneurysms or
SAH [68].
However, the wealth of recently published data on UIA
treatment has led many physicians to implement their own
protocolsbasedonthestudiestheyﬁndmostcredibleamong
theliterature.Manyemphasizeaneurysmsizeintheirclinical
evaluation, but these decisions are complex and require
considerationofmanyotherfactorsaswell.Theﬁrstdecision
is whether to treat. At Columbia University as of 2007,
the neurosurgical team reported that their interpretation
of the literature and the experience of their microsurgeons
and endovascular surgeons have led them to believe that
all symptomatic aneurysms, aneurysms from 5–10mm in
patients under 60 years old, and aneurysms >10mm in
patient under 70 years old should be strongly considered for
treatment [69].
Comparatively, the management summary submitted by
Robert Brown, a Professor of Neurology at the Mayo Clinic
College of Medicine, cites diﬀerent size thresholds, a more
aggressive attitude towards intervention and an emphasis
on patient perspective [70]. He recommends that treatment
be considered for UIAs >12mm unless the patient is older
or has signiﬁcant comorbidities, for UIAs 7–12mm, in
particularthosethataresymptomatic,inspeciﬁclocationsor
are harbored among younger patients, and for UIAs <7mm
on a case-by-case basis especially for younger patients.
F u r t h e r ,w h i l es o m es u r g e o n sr e c o m m e n dm i c r o s u r g i c a l
clipping as the ﬁrst treatment choice because of its proven
long-termeﬃcacy[69],theprevailingthoughtseemstofavor
endovascular coiling as the more amenable ﬁrst-line treat-
ment due to its low morbidity, mortality, and complication
rates [71]. Still, this dispute overshadows the fact that each
technique has its own strengths and weaknesses and that
these treatment decisions should be evaluated individually
based on patient and aneurysm characteristics. Table 2 sum-
marizes the treatment recommendations referenced above.International Journal of Vascular Medicine 9
4. Conclusion
Management of UIAs is characterized by an outwardly sim-
plecomparisonbetweenriskofobservationandriskofinter-
vention.However,deeperanalysisshowsthatthesesituations
are anything but simple. In this paper, we have summarized
the patient-speciﬁc and aneurysm-speciﬁc factors that aﬀect
the natural history of these lesions. Additionally, safety
and eﬃcacy data are presented for both surgical clipping
and endovascular coiling to illustrate the risks and beneﬁts
of treatment. Review of current treatment guidelines can
provide practitioners with a framework to make appropriate
treatment decisions when faced with UIA cases, but each
patient should be approached on a case-by-case basis so as
to consider the multifactorial nature of the disease.
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